News
2-September 2010 – LGC
Genomics acquires the new Illumina HiSeq
2000
The new Illumina HiSeq 2000 is added to LGC Genomics’
next generation sequencing portfolio
LGC Genomics, the genomics
division of LGC, announces the acquisition of the latest next
generation sequencing technology Illumina HiSeq 2000 to its
sequencing portfolio at its Berlin facilities.
The Illumina HiSeq 2000 sequencing platform -
together with the Roche GS FLX Titanium and the high capacity
Sanger sequencing ABI 3730xl technologies - will allow LGC Genomics
to offer the whole range of next generation sequencing services.
The sequencing platforms support various applications including de
novo sequencing, re-sequencing, transcriptome and metagenome
sequencing and they also extend the range of bioinformatic services
on offer.
The Illumina HiSeq 2000 has the potential to
generate up to 2 billion reads or 200 Gbp per run. It therefore
improves the speed of large and complex sequencing projects and
considerably reduces costs for the customers. The new next
generation sequencing system will be integrated in the Berlin
facility and several new positions for highly qualified scientists
will be generated at LGC Genomics in Berlin.
John McQuillian – Managing Director of LGC
Genomics Division commented: “Following the creation and
rebranding of LGC Genomics as an independent division in April this
year, adding the latest next generation sequencing technology to
our portfolio is the next step on our path as LGC Genomics develops
its operations to become Europe's leading genomics services
provider.
- Ends -
Notes to editors
About LGC Genomics
LGC
Genomics is a new division of the international science-based LGC
Group and was established in April 2010 as part of a strategic
reorganisation of LGC’s operational structure. LGC Genomics
combines the strengths of the LGC Group’s former AGOWA genomics
business – based in Berlin - with LGC’s ambitions for growth in the
rapidly expanding international genomics market.
LGC Genomics delivers next generation
sequencing services, DNA sequencing, genomic services, nucleic acid
extraction services and DNA extraction products.
LGC is an international science-based company
and market leader in analytical, forensic and diagnostic services
and reference standards (www.lgc.co.uk).LGC operates
internationally through four divisions - LGC Forensics, LGC
Genomics, LGC Standards and LGC Science & Technology. The LGC
Group employs 1500 staff in 28 laboratories and centres across
Europe as well as in India and China.
For more information
Contact: Franziska Sommerfeld; Tel: +49 (0)30 5304 2204; Email:
franziska.sommerfeld@lgcgenomics.com